Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

• Gerd R. Burmester,
• Laura C. Coates,
• Stanley B. Cohen,
• Yoshiya Tanaka,
• Ivana Vranic,
• Edward Nagy,
• Irina Lazariciu,
• All-shine Chen,
• Kenneth Kwok,
• Lara Fallon,
• Cassandra Kinch

Affiliations

Gerd R. Burmester

Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin

Laura C. Coates

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre

Stanley B. Cohen

Metroplex Clinical Research Center and Department of Internal Medicine, The University of Texas Southwestern Medical Center

Yoshiya Tanaka

First Department of Internal Medicine, University of Occupational and Environmental Health Japan

Ivana Vranic

Pfizer Ltd

Edward Nagy

Pfizer Ltd

Irina Lazariciu

Pfizer Inc

All-shine Chen

Pfizer Inc

Kenneth Kwok

Pfizer Inc

Lara Fallon

Inflammation and Immunology, Pfizer Canada ULC

Cassandra Kinch

Inflammation and Immunology, Pfizer Canada ULC